about
sameAs
Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoFibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1BB0172, a Borrelia burgdorferi outer membrane protein that binds integrin α3β1.Thrombotic thrombocytopenic purpura associated with abacavir in a patient with HIV infection.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapySevere Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibitionThrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ERFactor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress.Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.Removal of the C-Terminal Domains of ADAMTS13 by Activated Coagulation Factor XI induces Platelet Adhesion on Endothelial Cells under Flow Conditions.Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C.Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
P2860
Q28584350-0D73E37F-BB1E-4BCA-B657-79B5060917FEQ28586832-645716E1-381B-45F7-AE96-7D959E173A98Q30628465-64ACE80C-9DD6-44AE-9FCC-D0D0CAF84697Q33359746-18B729CB-B00D-481E-AC3D-1938BD322AB4Q33369765-39E5436A-1515-4064-BC05-91D17F44A0ABQ33382766-0134EF36-EB2E-4D33-96E9-0F5E9D752D5CQ33419829-81587994-FED0-40FF-9C88-8F99CA1DD147Q33747963-C09AD192-F766-447D-9124-7FC0149134B1Q34121211-33CDFDD9-156B-4339-A3B9-836FC0493019Q35121231-0D494CFD-F1E0-4131-9A56-92850E126897Q35579858-0DF7C7CF-87EA-4160-8ECA-FC3C3D49A70BQ35661984-83AD4DAC-7F57-4CFA-A947-362017C99EA4Q36174498-B17C0C50-3540-4D29-A7D1-19A19389ABEFQ36604393-AD66A769-28FD-4A2F-B278-3E82C02A3E99Q41986602-6F8C23D7-C022-4D22-A89C-35F5AAE3A71EQ49477336-3E11CEF5-697D-4077-8130-6068877628B3Q50052142-859401E5-291C-42D6-BB0E-39368AF5E7DBQ52108061-D7D91688-8800-42E5-B33A-F4C93125E9FFQ52345676-7865CA96-C4B8-4D17-9D82-12930133D537
P2860
description
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
scientific article (publication date: September 2002)
@en
vedecký článok (publikovaný 2002-09)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-09)
@nl
наукова стаття, опублікована у вересні 2002
@uk
مقالة علمية (نشرت في سبتمبر 2002)
@ar
name
ADAMTS13 and TTP
@ast
ADAMTS13 and TTP
@en
ADAMTS13 and TTP
@nl
type
label
ADAMTS13 and TTP
@ast
ADAMTS13 and TTP
@en
ADAMTS13 and TTP
@nl
prefLabel
ADAMTS13 and TTP
@ast
ADAMTS13 and TTP
@en
ADAMTS13 and TTP
@nl
P1476
ADAMTS13 and TTP
@en
P2093
Elaine M Majerus
P304
P356
10.1097/00062752-200209000-00001
P407
P577
2002-09-01T00:00:00Z